Three Fool.com contributors have identified no-brainer stocks to buy for under $100 right now. Here's why they picked two big ...

There's nothing like a top-level management departure to get investors worried about a publicly traded company. Investors in ...

But the surge in Chinese pharma is still ringing alarm bells. “China’s rise in biotech is a threat to the United States,” ...

Frost & Sullivan celebrates companies for their outstanding achievements at the Frost & Sullivan Best Practices Awards Gala ...

To tackle fake drugs, the Union health ministry will soon mandate barcodes or QR codes on certain medicines. This applies to ...

The biotech sector remains one of the most dynamic areas of the market, driven by clinical breakthroughs, regulatory ...

The results, released on Thursday, show that 93.49 per cent of women who appeared for the test qualified, compared to 91.61 ...

Please don’t create your company for venture.” Industry experts at Summerfest Tech share insider tips on how biotech startups ...

Delhi's Urban Development Minister Ashish Sood conducted a surprise inspection of five night shelters operating at the Sarai ...

Berhampur: The BJD on Thursday demanded a CBI inquiry into the allegedly rape of a 17-year-old girl by the owner of a private ...

Eupraxia Pharmaceuticals Inc. EPRX-T is a clinical-stage biotechnology company leveraging delivery technologies to optimize ...

Incyte has hired veteran biotech executive Bill Meury to succeed Herve Hoppenot at the helm of the biopharmaceutical company.